NNI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Nelnet Inc (NNI) is not a strong buy at this time for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The company's financial performance shows significant declines in revenue, net income, and gross margin, which raises concerns about its growth potential. While the technical indicators suggest a neutral to slightly bullish trend, there are no strong positive catalysts or trading signals to justify immediate action. Analysts maintain a Hold rating with modest price target adjustments, and there is no recent activity from influential figures or Congress to indicate strong sentiment. For now, holding off on this investment is the most prudent choice.
The MACD is positive at 0.5 and contracting, indicating a slight bullish momentum. The RSI is neutral at 48.665, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels are Pivot: 130.019, R1: 135.356, S1: 124.682, R2: 138.652, S2: 121.386. Overall, the technical indicators suggest a neutral to slightly bullish trend.
The appointment of Evan Claudeanos as Managing Director of Product and Engineering to lead the Project Horizon platform transformation could enhance innovation in higher education payment technology. The dismissal of the lawsuit against the SAVE student loan repayment plan may create opportunities for Nelnet in the student lending space.
Significant declines in financial performance metrics, including revenue (-72.01% YoY), net income (-8.36% YoY), and gross margin (-122.18% YoY), raise concerns about the company's growth and profitability. Analysts maintain a Hold rating, reflecting a lack of strong confidence in the stock's near-term potential.
In Q4 2025, Nelnet's revenue dropped significantly by -72.01% YoY to $159.2M. Net income decreased by -8.36% YoY to $56.77M, and EPS fell by -7.65% YoY to 1.57. Gross margin turned negative at -13.49%, a sharp decline of -122.18% YoY, highlighting substantial financial challenges.
Analysts at TD Cowen raised the price target from $135 to $140 but maintained a Hold rating. The adjustments reflect macroeconomic factors and secular growth in specialty finance sectors, but no strong buy signals were provided.
